nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts Presented at the 13th Annual International Congress on Hematologic Malignancies February 11–15, 2009; Whistler, British Columbia
|
|
|
2009 |
9 |
2 |
p. 171-182 12 p. |
artikel |
2 |
A Pharmacokinetic Study Evaluating the Relationship Between Treatment Efficacy and Incidence of Adverse Events with Thalidomide Plasma Concentrations in Patients with Refractory Multiple Myeloma
|
Kodama, Tomoko |
|
2009 |
9 |
2 |
p. 154-159 6 p. |
artikel |
3 |
Biomarkers and Prognosis in Malignant Lymphomas
|
Hagenbeek, Anton |
|
2009 |
9 |
2 |
p. 160-166 7 p. |
artikel |
4 |
CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma
|
Mitrovic, Zdravko |
|
2009 |
9 |
2 |
p. 133-137 5 p. |
artikel |
5 |
Meeting Highlights from: The 50th Annual Meeting of the American Society of Hematology; San Francisco, CA; December 6–9, 2008
|
Cunningham, Sonia |
|
2009 |
9 |
2 |
p. 124-132 9 p. |
artikel |
6 |
Melphalan, Prednisone, and Lenalidomide for Newly Diagnosed Myeloma: Kinetics of Neutropenia and Thrombocytopenia and Time-to-Event Results
|
Palumbo, Antonio |
|
2009 |
9 |
2 |
p. 145-150 6 p. |
artikel |
7 |
Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial
|
Iannitto, Emilio |
|
2009 |
9 |
2 |
p. 138-144 7 p. |
artikel |
8 |
Successful Use of Full-Dose Dexamethasone, High-Dose Cytarabine, and Cisplatin as Part of Initial Therapy in Non-Hodgkin and Hodgkin Lymphoma with Severe Hepatic Dysfunction
|
McCarthy, Jeanne |
|
2009 |
9 |
2 |
p. 167-170 4 p. |
artikel |
9 |
The Role of Biomarkers in the Management of Patients with Lymphoma: Promise Versus Reality
|
Hsi, Eric D. |
|
2009 |
9 |
2 |
p. 121-123 3 p. |
artikel |
10 |
Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patients with Multiple Myeloma Treated with Bortezomib
|
Pour, Ludek |
|
2009 |
9 |
2 |
p. 151-153 3 p. |
artikel |